Validation and determination of taselisib, a β-sparing phosphoinositide 3-kinase (PI3K) inhibitor, in human plasma by LC-MS/MS. (Q33467956)
Jump to navigation
Jump to search
scientific article published on 20 April 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Validation and determination of taselisib, a β-sparing phosphoinositide 3-kinase (PI3K) inhibitor, in human plasma by LC-MS/MS. |
scientific article published on 20 April 2016 |
Statements
1 reference
Validation and determination of taselisib, a β-sparing phosphoinositide 3-kinase (PI3K) inhibitor, in human plasma by LC-MS/MS. (English)
1 reference
X Ding
1 reference
K Faber
1 reference
J McKnight
1 reference
D Dorshorst
1 reference
J A Ware
1 reference
B Dean
1 reference
1 reference
Identifiers
1 reference